Caribou Biosciences, Inc. (CRBU) Tops Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts CRBU Hot Sheet
Join SI Premium – FREE
Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q4 EPS of ($0.28), $0.04 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $3.94 million versus the consensus estimate of $2.17 million.
For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
